Stanford, CA, United States of America

Todd A Aguilera

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Todd A. Aguilera in Biotechnology

Introduction

Todd A. Aguilera, based in Stanford, California, has made significant contributions to the field of biotechnology through his inventive work. With a total of three patents, he continues to push the boundaries of medical science, focusing particularly on cancer therapies.

Latest Patents

Among his latest patents are innovative developments in fusion proteins. One notable invention is the SPD-1 variant# FC fusion proteins, which introduces novel sPD-1 variant—Fc fusion proteins. This invention is centered on enhancing the mechanisms that can impact cancer treatment efficacy. Another crucial patent encompasses receptor-based antagonists of the programmed cell death 1 (PD-1) pathway. This invention outlines compositions and methods aimed at alleviating cancer or infections by administering a therapeutically effective amount of a pharmaceutical composition featuring an isolated PD-1 variant polypeptide. These polypeptides can inhibit the activity of PD-1 through various mechanisms, thereby offering new avenues for therapeutic intervention.

Career Highlights

Todd's career highlights include his significant roles at renowned institutions. He has worked at Leland Stanford Junior University, where he contributed to advancing research in the biological sciences. Additionally, his tenure at Akso Biopharmaceutical, Inc. demonstrates his commitment to transforming research into practical applications for patient care.

Collaborations

Throughout his career, Todd has collaborated with esteemed colleagues in his field, including Amato J. Giaccia and Mihalis S. Kariolis. Their collective expertise enhances the innovative projects they undertake, fostering a vibrant environment for research and development in biotechnology.

Conclusion

Todd A. Aguilera exemplifies the role of a forward-thinking inventor, contributing to crucial advancements in cancer treatment and therapeutics. His patents stand as a testament to his dedication and innovative spirit in the relentless pursuit of improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…